Relationship of penicillin resistance to mortality in pneumococcal pneumonia

Dixon RE: Economic costs of respiratory tract infections in the United States. Am J Med 1985, 78:45.

National Center for Health Statistics: National hospital discharge survey: Annual summary 1990. Vital Health Stat 1992, 13:1–225.

Marston BJ, Plouffe JF, File TM Jr, et al.: Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997, 157:1709–18.

Fine MJ, Smith MA, Carsen CA, et al.: Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996, 275:134–141.

Lipsky B, Boyko EJ, Inui TS, et al.: Risk factors for acquiring pneumococcal infections. Arch Int Med 1986, 146:2179–2185.

Plouffe JF, Breiman RF, Fackman RR: Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 1996, 275:194–198.

Ferrándiz MJ, Fernoll A, Liñares J, de La Campa AG: Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2000, 44:840–847. This is a good study focusing on an important topic.

Bartlett JG, Dowell SF, Mandell LA, et al.: Practice guidelines for the management of community-acquired pneumonia in adults. Guidelines from the Infectious Diseases Society of America. Clin Inf Dis 2000, 31:347–382.

Mandell LA, Marrie TJ, Grossman RT, et al.: Canadian guidelines for the initial management of communityacquired pneumonia. An evidence-based update for the Canadian Infectious Disease Society. The Canadian Community-Acquired Working Group. Clin Inf Dis 2000, 31:383–421. Interesting update.

Heffelfinger JD, Dowell SF, Jorgensen JH, et al.: Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000, 150:1399–1408.

Feikin DR, Schuchat A, Kolczak M, et al.: Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance 1995–1997. Am J Public Health 2000, 90:223–229.

Turett GS, Blum S, Fazal B, et al.: Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Inf Dis 1999, 29:321–327.

Buckingham SC, Brown SP, San Joaquin VH: Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr 1998, 132:174–176.

Dowell SF: Failure of treatment of pneumonia associated with highly resistant pneumococci in a child. Clin Inf Dis 1999, 9:462–463.

Daum RS, Nachman JP, Leitch CD, Tenover FC: Nosocomial epiglottitis associated with penicillin- and cephalosporinresistant Streptococcus pneumoniae bacteremia. J Clin Microbiol 1994, 32:246–248.

Chesney PJ, Davis Y, English BK, Wang WC: Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease. Pediatr Infect Dis J 1995, 14:1013–1014.